Drug Chatter -- Tracking biopharma stock chatter

Profile for La Jolla Pharmaceutical Company (LJPC)

« Back to company index

LJPC Chatter Timeline

Stock Ticker for LJPC

Most Active Tweeters for LJPC

UserTweets
@1MinuteStock 4
@upstocks13 4
@ZorTrades 3
@storminvestor 3
@profit_m_c 3

Recent Tweets for LJPC

MaisaCorp @MaisaCorp
$LJPC Plans to Submit European Application On Low Blood Pressure Drug in Q3
September 25th 2017, 3:09pm
stockboardinc @stockboardinc
$LJPC La Jolla Pharmaceutical Company Announces Intent to Submit Marketing Authorization Application for L... - https://t.co/5iODG1S77N
September 25th 2017, 12:09pm
danrocks4 @danrocks4
LJPC is number 88 for the largest percentage gain out of 100 stocks. $LJPC La Jolla Pharma is up +11.11% in th https://t.co/DCIJ4uDHl6
September 25th 2017, 11:09am
SleekMoneycom @SleekMoneycom
Somewhat Favorable News Coverage Somewhat Unlikely to Affect La Jolla Pharmaceutical $LJPC Stock Price https://t.co/dSNncgyn3Q
September 25th 2017, 9:09am
Briefingcom @Briefingcom
$LJPC: La Jolla Pharm: EMA CHMP has issued favorable Scientific Advice regarding the EU regulatory pathway for... https://t.co/KZIlqKrtRU
September 25th 2017, 8:09am
PredatorDiaries @PredatorDiaries
@JuliaSkripkaSer I'm announcing my intent to believe that there is no viable commercial market for $LJPC's drug
September 25th 2017, 7:09am
stocknewsdotcom @stocknewsdotcom
$LJPC EMA CHMP has issued favorable Scientific Advice regarding the EU regulatory pathway for LJPC-501 for the tre… https://t.co/5vxE332whD
September 25th 2017, 6:09am
Traderideas1 @Traderideas1
RT @odibro: $LJPC Announces Intent to Submit Marketing Authorization Application for LJPC-501 in the Third Quarter of 2018
September 25th 2017, 6:09am
odibro @odibro
$LJPC Announces Intent to Submit Marketing Authorization Application for LJPC-501 in the Third Quarter of 2018
September 25th 2017, 6:09am
mgutierrez_apex @mgutierrez_apex
$LJPC La Jolla Pharmaceutical Company Announces Intent to Submit Marketing Authorization Application for LJPC-501 in the Third Quarter of 18
September 25th 2017, 6:09am
TheMarketsDaily @TheMarketsDaily
La Jolla Pharmaceutical $LJPC Earning Somewhat Favorable Media Coverage, Analysis Shows https://t.co/nag3lnouWm
September 24th 2017, 10:09am
CubbieBears @CubbieBears
$LJPC example of one that close to breaking out of multi month base; but no sales & earnings https://t.co/O96Zh08vvy
September 23rd 2017, 9:09pm
1MinuteStock @1MinuteStock
We calculated 63-day Expected Return of $LJPC for you: 25.93% https://t.co/EMkqvnHZEg
September 23rd 2017, 9:09pm
1MinuteStock @1MinuteStock
Do you know that #Book Value for $LJPC is $6.04 https://t.co/bz5w773vDx
September 23rd 2017, 7:09pm
wulamkam @wulamkam
$ljpc expansion breakout ' https://t.co/eThqqvGQgo
September 23rd 2017, 12:09pm
ntrsvic221 @ntrsvic221
$ljpc on watch for break over 37.75 https://t.co/EfVwKKGNgn
September 23rd 2017, 4:09am
upstocks13 @upstocks13
$LJPC target almost reached, has potential to surpass 40 this time.. https://t.co/YQqAmb4PmB
September 22nd 2017, 2:09pm
ArtDoyle2017 @ArtDoyle2017
$LJPC - This data is NOT indicative of a survival benefit https://t.co/eL7k7PX1ct
September 22nd 2017, 1:09pm
danrocks4 @danrocks4
LJPC is number 48 for the largest percentage gain out of 100 stocks. $LJPC La Jolla Pharma is up +14.69% in th https://t.co/br3lnAEOeF
September 22nd 2017, 10:09am
danrocks4 @danrocks4
LJPC is number 79 for the largest percentage gain out of 100 stocks. $LJPC La Jolla Pharma is up +11.50% in th https://t.co/dT4W7Y0TMk
September 21st 2017, 11:09am
upstocks13 @upstocks13
$LJPC sold 50% at 35. stop moved to 34 https://t.co/bXpJamLkNz
September 21st 2017, 9:09am
Briefingcom @Briefingcom
$LJPC: La Jolla Pharm abstract was published online that includes results from a pre-specified analysis of the... https://t.co/UuNcDISBFd
September 20th 2017, 6:09pm
paynej247 @paynej247
RT @odibro: $LJPC Analysis of ATHOS-3 Indicates Survival Benefit in LJPC-501-Treated Pats w/Relatively Low Angiotensin II State https://t.c…
September 20th 2017, 5:09pm
odibro @odibro
$LJPC Analysis of ATHOS-3 Indicates Survival Benefit in LJPC-501-Treated Pats w/Relatively Low Angiotensin II State https://t.co/uKgSTspIa8
September 20th 2017, 5:09pm
stocknewsdotcom @stocknewsdotcom
$LJPC Abstract was published online that includes results from a pre-specified analysis of the ATHOS-3 https://t.co/QSM2ORxP8l
September 20th 2017, 4:09pm
stockboardinc @stockboardinc
$LJPC Prespecified Analysis of ATHOS-3 Indicates Survival Benefit in LJPC-501-Treated Patients with Relati... - https://t.co/uQvaC7teX4
September 20th 2017, 4:09pm
NewsToDesk @NewsToDesk
$LJPC: Prespecified Analysis of ATHOS-3 Indicates Survival Benefit in LJPC …: https://t.co/CRtoKp8Llz
September 20th 2017, 4:09pm
profit_m_c @profit_m_c
and there is $LJPC at target profit of 34.75 if you held to it
September 20th 2017, 3:09pm
profit_m_c @profit_m_c
Out of $LJPC at 34.60 from entry at 34.05 slight below the target profit of 34.75 .. stock is so spready and locked in 55 cents
September 20th 2017, 3:09pm
upstocks13 @upstocks13
$LJPC looking good https://t.co/fAoZdkVYik
September 20th 2017, 2:09pm
EBUYUKARSLAN @EBUYUKARSLAN
@OptionsHawk VERY LOW VOLUME this $LJPC and doubple top here. so i would not pump it.
September 20th 2017, 2:09pm
upstocks13 @upstocks13
$LJPC going nicely https://t.co/UABN9xyNpb
September 20th 2017, 2:09pm
profit_m_c @profit_m_c
$LJPC launch at 34.05 target at 34.75 abort at 33.66
September 20th 2017, 2:09pm
tymorapro @tymorapro
$LJPC: Exc 1WkHIGH=33.96, hits:1, Rng:9%, ch:+3.0%, 0NewHi:BrkPLo+PHi[+4.9%], AtPivR2, 22:3Accel+, allTFs+, lowFlt:12M, HiPctSht[39%:10d]
September 20th 2017, 2:09pm
DonnaYoungDC @DonnaYoungDC
#FDA #BRUDAC meeting for $LJPC's oral #testosterone #TLANDO; no date yet, but before Feb. 8 PDUFA https://t.co/e3jaH1K3Gj #pharma #biotech
September 20th 2017, 8:09am
1MinuteStock @1MinuteStock
Btw, Estimated #Earnings Per Share for $LJPC is $-1.28 it's -3.9% of the current price https://t.co/kCl7xJlBDX
September 19th 2017, 3:09pm
SwingTradeBot @SwingTradeBot
Recent $LJPC technical alerts: Crossed Above 50 DMA plus 5 more alerts... https://t.co/mF0YW0gKsF
September 19th 2017, 2:09pm
Doozio @Doozio
@howardlindzon biotech is so early in this move and the longterm chart is tightening up to perfection. Re $ljpc
September 19th 2017, 2:09pm
Doozio @Doozio
$ljpc you ever seen a prettier cup n handle on that monthly? So little recent overhead.. N feels SOOOO early in this biotech move! YO
September 19th 2017, 2:09pm
Doozio @Doozio
$ljpc the coiling/tightening continues!!! Gonna be a monster ? eventually barring a grenade.
September 19th 2017, 2:09pm
DKOptions @DKOptions
$LJPC 2000 Dec 32 puts being sold to open here
September 18th 2017, 12:09pm
1LuckyJimmy @1LuckyJimmy
LJPC +1.70 total advance today 11:40 ET. La Jolla Pharma $LJPC 33.18 Stock hit a High of 33.70 and 31.52 Low w https://t.co/ljnHJ9W5n3
September 18th 2017, 12:09pm
SpeedyCalls @SpeedyCalls
$LJPC 32 Puts SELLING Activity expiring on 15th Dec, Vol 1600
September 18th 2017, 12:09pm
isheaven1 @isheaven1
RT @OptionsHawk: $LJPC coiled name in Biotech climbing today with 14,500 Dec $30 short puts in OI
September 18th 2017, 11:09am
OptionsHawk @OptionsHawk
$LJPC coiled name in Biotech climbing today with 14,500 Dec $30 short puts in OI
September 18th 2017, 10:09am
surveyist @surveyist
RT @zbiotech: $LJPC touts the 'de-risked' nature of their pipeline...perhaps somewhat from regulatory standpoint, but not a marketing one
September 18th 2017, 10:09am
zbiotech @zbiotech
$LJPC touts the 'de-risked' nature of their pipeline...perhaps somewhat from regulatory standpoint, but not a marketing one
September 18th 2017, 10:09am
ApexOneTrading @ApexOneTrading
$LJPC nice breakout from that flag. No pullbacks yet
September 18th 2017, 10:09am
TheMarketsDaily @TheMarketsDaily
La Jolla Pharmaceutical $LJPC Earning Somewhat Positive News Coverage, Report Finds https://t.co/QOJpMktZpX
September 18th 2017, 9:09am
Vtradez @Vtradez
RT @ZorTrades: $LJPC $JMEI swing of interest on the long side if and only if they can get thru yday's high +.10cents https://t.co/J27nGlVa7J
September 18th 2017, 8:09am

Contact © thinkBiotech LLC 2004 - 2017. All rights reserved.